C
Causara
Process
08Process and timelineNav · Process

Process and timeline

Process windows from tier election to first distributions, and the decision points that gate each window.

Figure · process timeline

From tier election to first distributions, on a single 18-month baseline.

  1. 1
    0–30 d
    Tier election

    Counterparty selects tier, indicative cheque, and cash/deferred ratio.

  2. 2
    30–90 d
    Confirmatory diligence

    Data room access, model walkthroughs, legal review of HoldCo / Causara docs.

  3. 3
    90 d–12 mo
    Signing & close

    Definitive SPA, deferred mechanism, lockup and tag/drag. Cash to seller.

  4. 4
    12–18 mo
    Distributions begin

    Layer 1 transactional economics first; Layer 2 recurring builds over fund life.

Near-term (0 to 30 days). Kai selects a tier and confirms the deferred payment election (cash settlement or stake reduction at window end). CEI, Hydra, and Kardeshev confirm the contribution matrix and the resulting GP economics split. Legal documentation for the share sale begins. The HUMAIN follow-up session per action item 1 of the 21 May 2026 MoM is scheduled.

Medium-term (30 to 90 days). Share sale closes. Cash portion paid; deferred balance recorded. HUMAIN proof-of-concept structuring completed. Series A SPV 1 reaches first close. Sovereign comfort letter scope clarified per action item 4 of the 21 May 2026 MoM.

Long-term (90 days plus). Distributions from Series A SPV 1 begin to settle deferred balances. HUMAIN proof-of-concept deployment; observed performance informs scaling decision. Series A SPV 2 and 3 deployments per the Series A programme timeline. HUMAIN scaling decision and, if affirmative, transition to Phase 2 (USD 1.5 to 3 billion) and Phase 3 (up to USD 10 billion) of the Series B programme.